Nuveen Asset Management LLC Sells 570,672 Shares of Maximus, Inc. (NYSE:MMS)

Nuveen Asset Management LLC trimmed its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 67.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 277,944 shares of the health services provider's stock after selling 570,672 shares during the period. Nuveen Asset Management LLC owned approximately 0.49% of Maximus worth $20,749,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its stake in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the period. V Square Quantitative Management LLC grew its stake in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd bought a new stake in shares of Maximus in the 4th quarter valued at approximately $54,000. IFP Advisors Inc grew its stake in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in shares of Maximus by 109.2% in the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after purchasing an additional 428 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

Shares of MMS traded down $0.67 on Thursday, hitting $71.97. The company's stock had a trading volume of 36,863 shares, compared to its average volume of 605,036. The company has a market capitalization of $4.06 billion, a PE ratio of 15.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a 50 day moving average price of $69.70 and a 200 day moving average price of $71.94.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Maximus's revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.57 EPS. On average, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.67%. The ex-dividend date is Thursday, May 15th. Maximus's payout ratio is currently 23.86%.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. The trade was a 11.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.